Bavencio 20 mg/mL concentrate for solution for infusion
NL75848.056.20
Approved small_molecule active
Quick answer
Bavencio 20 mg/mL concentrate for solution for infusion for urothelial cancer, Bladder cancer, muscle invasive bladder cancer is a Approved program (small_molecule) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- urothelial cancer, Bladder cancer, muscle invasive bladder cancer
- Phase
- Approved
- Modality
- small_molecule
- Status
- active